Certain Photodynamic Therapy Systems, Components Thereof, and Pharmaceutical Products Used in Combination With the Same; Notice of a Commission Determination To Review in Part a Final Initial Determination Finding a Violation of Section 337; Request for Written Submissions on Remedy, the Public Interest, and Bonding

Brief takeaway: The ITC is reviewing part of a judge's finding that certain photodynamic therapy systems violate Section 337, and is asking for input on possible import remedies before it decides.

What changed: According to the notice, the Commission determined to review in part a final initial determination by the administrative law judge that found a violation of Section 337 of the Tariff Act of 1930. The notice states the Commission is requesting written submissions on remedy, the public interest, and bonding on a set schedule.

Who's affected: The notice names photodynamic therapy systems, components thereof, and pharmaceutical products used in combination with the same. It does not specify HTS codes or countries of origin in this text. If a violation is ultimately found, Section 337 cases can lead to exclusion orders affecting imports of the covered products regardless of where they are made.

What to review:
- Review whether your products fall within the categories described (photodynamic therapy systems, their components, or related pharmaceutical products).
- Confirm with your broker or trade counsel whether this investigation may affect your imports and how to track its outcome.
- Check the notice for the submission schedule and deadlines if you intend to file comments.
- Review whether any potential exclusion order or bonding requirement could later apply to your shipments.

This is general information, not legal advice and not a compliance determination — confirm specifics with a licensed customs broker or trade counsel.